Table 1. Bacterial strains and plasmids used in this work.
Strains or plasmids | Relevant characteristicsa | Reference or source |
---|---|---|
Escherichia coli | ||
DH5 α | F−Φ80lac Z ΔM15 Δ(lac ZYA-arg F) U169 rec A1 end A1 hsd R17(rk−,m) pho A sup E44 thi-1 gyr A96 rel A1 λ− | Gibco BRL, Life Technologies |
BL21 Codon plus (DE3) RIL | F−ompThsdS (r m) dcm+galλ(DE3) end A Hte [argU ileY leuW Camr ] | Novagen |
22bA/RIL | BL21 Codon plus (DE3) RIL harboring 22bA, Ampr, Camr | This work |
28Aa/RIL | BL21 Codon plus (DE3) RIL harboring 28aA, Kanr, Camr | This work |
pEA/RIL | BL21 Codon plus (DE3) RIL harboring pEA, Kanr, Camr | This work |
pEAX1/RIL | BL21 Codon plus (DE3) RIL harboring pEAX1, Kanr, Camr | This work |
AX1R2/RIL | BL21 Codon plus (DE3) RIL harboring pEAX1 and pER2, Kanr, Ampr, Camr | This work |
Plasmids | ||
pET22b | Expression vector, C-terminal 6 ×His-tagged sequences, Ampr | Novagen |
pET28a | Expression vector, N-terminal 6 ×His-tagged sequences, Kanr | Novagen |
pRSFDuet | Expression vector which contains two multiple cloning sites (MCS), N-terminal 6 ×His-tagged sequences, Kanr | Novagen |
pETDuet | Expression vector which contains two multiple cloning sites (MCS), N-terminal 6 ×His-tagged sequences, Ampr | Novagen |
22bA | pET22b containing doxA coding region, Ampr | This work |
28aA | pET28a containing doxA coding region, Kanr | This work |
pEA | pRSFDuet containing doxA coding region, Kanr | This work |
pEAX1 | pRSFDuet containing doxA and fdx1 coding region, Kanr | This work |
pER2 | pETDuet containing fdr2 coding region, Ampr | This work |
Notes.
Kanr, Ampr and Camr indicate resistance to kanamycin, ampicillin and chloramphenicol, respectively.